Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
The University of Medicine and Dentistry of New Jersey (UMDNJ) hospital's chief quality officer estimates that approximately “100,000 people walk through the public hospital's door every year.” How many of these patients would go out of their way to be treated at a different ' more specifically, a private ' hospital, if aware of the statutory limitations that may impact their ability to recover non-economic damages in the event they are subjected to medical malpractice?
New Jersey is a litigious state and, prior to 1972, governmental entities and their employees faced the same exposure in civil actions as private corporations and citizens. In 1972, with the intent to limit the potential civil liability of public entities and public employees, New Jersey's Legislature enacted the Tort Claims Act (TCA), which is codified at New Jersey Statutes Annotated (N.J.S.A.) 59:1-1, et seq.'
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.